Biosynthetic Potential of Inonotus Obliquus in Symbiosis With Bacterial Cellulose: Optimisation and Prospects

  • Mikhail A Parshenkov Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia https://orcid.org/0009-0004-7170-8783
  • Polina P Skovorodko Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia https://orcid.org/0009-0000-5624-4731
  • Danila A Petrusevich Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia https://orcid.org/0009-0005-2283-6372
  • Shagun N Makaeva Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia https://orcid.org/0009-0008-3396-6684
  • Svetlana G Osipova Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia https://orcid.org/0009-0006-6457-9543
  • Gumru Ibragimova Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia https://orcid.org/0009-0007-0478-7137
  • Alexandra O Istyagina Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia https://orcid.org/0009-0001-3295-8462
  • Kristina A Balaeva Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia https://orcid.org/0009-0002-2930-6006
Keywords: Inonotus obliquus, Cellulose, bacterial, Antioxidants, Activity, Anti-inflammatory effects, Biotechnological cultivation, Phytochemicals

Abstract


Background/Aim: Inonotus obliquus, commonly known as the Chaga mushroom, is an extensively studied source of bioactive compounds, including polyphenols, triterpenoids and polysaccharides. These metabolites exhibit potent antioxidant, anti-inflammatory and immunomodulatory properties, underscoring I obliquus as a valuable resource for advanced biopharmaceuticals and functional therapeutics. Yet, achieving consistent and high-yield biosynthesis of these compounds remains challenging. Aim of this study was to develop a biotechnological approach leveraging co-cultivation with the bacterial cellulose producer Gluconacetobacter hansenii to improve both the yield and stability of these bioactive metabolites.

Methods: I obliquus was cultivated on solid and liquid-phase substrates, with and without G hansenii co-cultivation. Biomass yield, morphological changes and growth dynamics were assessed. Total phenolic content and antioxidant activity were quantified using the Folin-Ciocalteu method and DPPH/ABTS assays. Anti-inflammatory properties were evaluated by measuring IL-6, TNF-α and IL-1β levels in LPS-stimulated THP-1 macrophages via ELISA.

Results: Co-cultivation with G hansenii resulted in a 1.8-fold increase in fungal biomass yield (30.6 g/L on HS medium) and a 1.3-fold enhancement in phenolic content (85.4 mg GAE/g) compared to monoculture. Extracts from HS medium exhibited the highest antioxidant activity (IC50 = 43.2 µg/mL in DPPH and 29.8 µg/mL in ABTS assays) and significantly reduced pro-inflammatory cytokine levels (IL-6 by 47.5 %, TNF-α by 42.8 % and IL-1β by 39.6 %) in LPS-stimulated macrophages. Morphological analysis revealed a denser, more organised fungal network under co-cultivation, suggesting improved metabolic efficiency and bioactive compound synthesis.

 

Conclusion: Co-cultivation with G hansenii provides a scalable and efficient strategy to enhance the bioactive potential of I obliquus. This approach significantly improves metabolite yield, antioxidant capacity and anti-inflammatory activity, opening new avenues for the development of standardised therapeutic formulations targeting oxidative stress and immune modulation.

 

Author Biographies

Mikhail A Parshenkov, Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia

Researcher at Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University)

Polina P Skovorodko, Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia

PhD Candidate at the Department of Biotechnology, A.P. Nelyubin Institute of Pharmacy, First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

Danila A Petrusevich, Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia

PhD Candidate at the Department of Biotechnology, A.P. Nelyubin Institute of Pharmacy, First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

Shagun N Makaeva, Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia

Student of the N.V. Sklifosovsky Institute of Clinical Medicine, First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

Svetlana G Osipova, Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia

Student of the N.V. Sklifosovsky Institute of Clinical Medicine, First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

Gumru Ibragimova, Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia

Student of the N.V. Sklifosovsky Institute of Clinical Medicine, First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

Alexandra O Istyagina, Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia

Student of the N.V. Sklifosovsky Institute of Clinical Medicine, First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

Kristina A Balaeva, Laboratory of Histology and Immunohistochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048, Trubetskaya St., 8/2, Moscow, Russia

Student of the N.V. Sklifosovsky Institute of Clinical Medicine, First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

References

Pons-Faudoa FP, Ballerini A, Sakamoto J, Grattoni A. Advanced implantable drug delivery technologies: transforming the clinical landscape of therapeutics for chronic diseases. Biomed Microdevices. 2019;21(2):47. doi:10.1007/s10544-019-0389-6.

Abdelrahim M, Esmail A, He AR, Khushman M, Rayyan Y. Advances in immunotherapy for transplant oncology. Cancers (Basel). 2024;16(13):2369. doi:10.3390/cancers16132369.

Redemptus P, Weraman, Umbu Roga A. Holistic therapy to improve quality of life in chronic disease patients. J Promkes. 2023;11:108–12. doi:10.20473/jpk.V11.I1SI.2023.108-112.

Bilotta MT, Antignani A, Fitzgerald DJ. Managing the TME to improve the efficacy of cancer therapy. Front Immunol. 2022;13:954992. doi:10.3389/fimmu.2022.954992.

Patil-Sen Y. Advances in nano-biomaterials and their applications in biomedicine. Emerg Top Life Sci. 2021;5(1):169–76. doi:10.1042/ETLS20200333.

Sajjad S, Umar U, Islam R, Alghamdi B, Iqbal MZ, Aljohani I, et al. Recent advancements in stem cell-based therapies. Pure Appl Biol. 2024;13:464–82. doi:10.19045/bspab.2024.130041.

Marrazzo P, O’Leary C. Repositioning natural antioxidants for therapeutic applications in tissue engineering. Bioengineering (Basel). 2020;7(3):104. doi:10.3390/bioengineering7030104.

Dar RA, Shahnawaz M, Ahanger MA, Majid IU. Exploring the diverse bioactive compounds from medicinal plants: A review. J Phytopharmacol. 2023;12(3):189–95. doi:10.31254/phyto.2023.12307.

Haider R, Mehdi A, Zehra A, Das GK, Ahmed Z. The challenges and future of advanced therapies. Int J Sci Multidiscip Res. 2024;2(4). doi:10.55927/ijsmr.v2i4.8628.

Szychowski KA, Skóra B, Pomianek T, Gmiński J. Inonotus obliquus – from folk medicine to clinical use. J Tradit Complement Med. 2020;11(4):293–302. doi:10.1016/j.jtcme.2020.08.003.

Peng H, Shahidi F. Bioactive compounds and bioactive properties of Chaga (Inonotus obliquus) mushroom: A review. J Food Bioact. 2020;12:245. doi:10.31665/jfb.2020.12245.

Anwaier G, Wen C, Caoili YN, Qi R. A review of the bioactive ingredients, pharmacological functions and mechanisms of Inonotus obliquus. Mini Rev Org Chem. 2020;17:203–618. doi:10.2174/1570193x17999200727203618.

Zhao Y, Zheng W. Deciphering the antitumoral potential of the bioactive metabolites from medicinal mushroom Inonotus obliquus. J Ethnopharmacol. 2021;265:113321. doi:10.1016/j.jep.2020.113321.

Ern P, Quan T, Yee F, Yin A. Therapeutic properties of Inonotus obliquus (Chaga mushroom): A review. Mycology. 2023;15:144–61. doi:10.1080/21501203.2023.2260408.

Denisenko TA, Vishnikin AB, Tsiganok LP. [Spectrophotometric determination of sum of phenolic compounds in plants using aluminum chloride, 18-molybdodiphosphate and Folin-Ciocalteu reagents]. Anal Kontrol. 2015;19(4):373–80. doi:10.15826/analitika.2015.19.4.012. Russian.

Sułkowska-Ziaja K, Robak J, Szczepkowski A, et al. Comparison of bioactive secondary metabolites and cytotoxicity of extracts from Inonotus obliquus isolates from different host species. Molecules. 2023;28(13):4907. doi:10.3390/molecules28134907.

Hoenerloh A, Ozkan D, Scott J. Multi-organism composites: combined growth potential of mycelium and bacterial cellulose. Biomimetics (Basel). 2022;7(2):55. doi:10.3390/biomimetics7020055.

Wang Y, Ouyang F, Teng C, Qu J. Optimization for the extraction of polyphenols from Inonotus obliquus and its antioxidation activity. Prep Biochem Biotechnol. 2021;51(9):852–9. doi:10.1080/10826068.2020.1864642.

Zhao W, Huang P, Zhu Z, Chen C, Xu X. Production of phenolic compounds and antioxidant activity via bioconversion of wheat straw by Inonotus obliquus under submerged fermentation with the aid of a surfactant. J Sci Food Agric. 2021;101(3):1021–9. doi:10.1002/jsfa.10710.

Wagle S, Thilakarathna W, Lee J, Rupasinghe HP. Anti-inflammatory effect of extracts of Inonotus obliquus and microalgae. Med Res Arch. 2024;12(2). doi:10.18103/mra.v12i2.5049.

Published
2025/04/30
Section
Original article